Abstract
OBJECTIVE: In recent years, serum C-reactive protein CRP has revealed dose-response relationships to various diseases such as arteriosclerosis, cardiovascular disease (CVD) and metabolic syndrome by using the high-sensitivity CRP (hs-CRP) assay method. The Center for Disease Control and Prevention has issued guidelines for the use of hs-CRP in clinical practice for CVD, stating relative risk categories (low, average, high) corresponding to approximate tertile values (<0.1, 0.1 to 0.3, >0.3 mg/dl, respectively).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
